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Take home message: The early delirium
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ICU admission. Identification of these high-
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delirium prevention.
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Abstract Rationale: Delirium in-
cidence in intensive care unit (ICU)
patients is high and associated with
poor outcome. Identification of high-
risk patients may facilitate its pre-
vention. Purpose: To develop and
validate a model based on data
available at ICU admission to predict
delirium development during a pa-
tient’s complete ICU stay and to
determine the predictive value of this
model in relation to the time of
delirium development. Meth-
ods: Prospective cohort study in 13
ICUs from seven countries. Multiple
logistic regression analysis was used
to develop the early prediction (E-
PRE-DELIRIC) model on data of the
first two-thirds and validated on data
of the last one-third of the patients
from every participating ICU. Re-
sults: In total, 2914 patients were
included. Delirium incidence was
23.6 %. The E-PRE-DELIRIC model
consists of nine predictors assessed at
ICU admission: age, history of cog-
nitive impairment, history of alcohol
abuse, blood urea nitrogen, admission
category, urgent admission, mean ar-
terial blood pressure, use of
corticosteroids, and respiratory fail-
ure. The area under the receiver
operating characteristic curve
(AUROC) was 0.76 [95 % confidence
interval (CI) 0.73–0.77] in the devel-
opment dataset and 0.75 (95 % CI
0.71–0.79) in the validation dataset.
The model was well calibrated.
AUROC increased from 0.70 (95 %
CI 0.67–0.74), for delirium that de-
veloped\2 days, to 0.81 (95 % CI
0.78–0.84), for delirium that devel-
oped[6 days.
Conclusion: Patients’ delirium risk
for the complete ICU length of stay
can be predicted at admission using
the E-PRE-DELIRIC model, allowing
early preventive interventions aimed
to reduce incidence and severity of
ICU delirium.
Keywords Intensive care unit 
Delirium  Clinical prediction  Adult
Introduction
Delirium is an acute organic brain dysfunction charac-
terised by disturbances of attention and cognition with a
fluctuating course, as a direct consequence of an under-
lying medical condition [1]. Delirium occurs frequently in
intensive care unit (ICU) patients [2, 3], and is associated
with poor outcome [3–6].
Systematic delirium assessment in ICU patients is
important to deliver adequate patient care by allowing
clinicians to detect and treat delirium at an early stage [7–
9]. Several promising interventions to prevent delirium
are available that target cognitive impairment, sleep de-
privation, immobility, and visual and hearing impairment
[10–15]. Although one study found no beneficial effects
of haloperidol as prophylaxis and treatment for ICU
delirium [16, 17], other studies have shown that prophy-
lactic haloperidol may exert beneficial effects in critically
ill patients [18, 19].
As part of a process to improve delirium care and to
further facilitate prevention of ICU delirium, identification
of high-risk patients is paramount [20], since these are the
most fragile patients who require maximum preventive
efforts [21]. Also, when preventive measures can be re-
stricted to high-risk patients, both the number of patients
who will be unnecessarily exposed to potential harmful
side effects [22] and costs are likely less. Moreover, the
effectiveness of prevention seems more pronounced in
patients with a higher risk for delirium [18]. Finally, pre-
diction of the ICU delirium risk provides relevant
information for family members and caregivers and will
facilitate stratification of patients in future delirium
1049
prevention studies. This stratification will positively in-
fluence the efficient use of research resources.
Currently, an ICU delirium prediction model is
available [23, 24]. However, the usefulness of this model
is limited by the fact that it requires predictors obtained
during the first 24 h of ICU admission. A relevant number
of ICU patients develop delirium within 24 h following
admission [25, 26], and preventive measures should ide-
ally be applied as early as possible. This calls for a
prediction model that can reliably predict delirium at the
time of ICU admission. Therefore, the objective of this
multinational study was to develop and validate a model
based on data available at ICU admission to predict the
development of delirium during a patient’s complete ICU
stay, and to determine the predictive value of this model
in relation to the time of development of delirium.
Some results of this study have been previously pre-
sented at the ISICEM congress in Brussels, March 2014,
the ESICM congress in Barcelona, October 2014 [27],
and the EDA congress in Cremona, November 2014 [28].
Methods
Design and study population
A multinational prospective cohort study was carried out
in 13 ICUs from seven countries (Australia, Belgium,
England, Germany, Spain, Sweden, and the Netherlands)
(Table E1 online data supplement). Each participating
ICU included all consecutive patients aged C18 years
(surgical, medical, neurology/neurosurgical, or trauma
patients) during a continuous period of approximately
three months between October 2011 and June 2012. Pa-
tients were excluded if: they were delirious at ICU
admission; had an ICU stay shorter than one day; were
unable to reliably assess for delirium (e.g., coma during
entire ICU stay; unable to understand the language spo-
ken; severely mentally disabled; serious receptive aphasia;
serious auditory or visual disorders); or if the compliance
rate of the CAM-ICU for delirium screening was\80 %
during an individual patient’s ICU stay (Fig. 1).
This study was approved by the medical ethical re-
search committee Arnhem-Nijmegen region, The
Netherlands (CMO Region Arnhem-Nijmegen, no.
2010/365), and conducted in accordance with the appli-
cable rules concerning the review of research ethics
committees and informed consent. All participating cen-
tres obtained ethics approval from their committees to
conduct the study.
Data collection
Data of 18 candidate delirium predictors were collected at
ICU admission in an electronic clinical report form using
a secured website. Candidate predictors were selected
based on the PRE-DELIRIC model [23, 24], a systematic
review about risk factors for delirium [29] and on expert
opinion [gathered during the annual meeting of the
working group Postoperative Delirium and Cognitive
Dysfunction (PoDeCoD) of the European Society of In-
tensive Care Medicine (ESICM)]. A proposal with
candidate predictors, based on the PRE-DELIRIC model
and the systematic review, was presented and discussed.
Candidate predictors were removed from/added to the
final list based on consensus of the members of this
working group.
Candidate predictors available at time of ICU admis-
sion were: age, gender, history of cognitive impairment
(history of dementia, mild cognitive impairment or
delirium), history of alcohol, nicotine and drugs abuse,
history of vascular disease, Glasgow Coma Scale (GCS)
score, diabetes, blood urea nitrogen (BUN), use of opiates
in the 24 h before ICU admission, use of anti-psychotics
before ICU admission, admission category (surgery,
medical, trauma, neurology/neurosurgery), urgent admis-
sion, mean arterial blood pressure (MAP), (strong
suspicion of) infection, use of corticosteroids, or respira-
tory failure (see Table E2 online data supplement for
exact definitions). Data on sedation and illness severity
(APACHE) were not collected, as these are not available
at ICU admission.
Fig. 1 Study flow chart
1050
Delirium assessment
All consecutive patients were screened for delirium by
trained ICU nurses at least once every 8- or 12-h shift
using the CAM-ICU. In accordance with previous pre-
diction studies [23, 24], delirium was diagnosed when the
CAM-ICU was positive [7, 30], and/or when a patient was
treated with haloperidol or other anti-psychotics because
of delirium (see Table E2). Patients were screened using
the CAM-ICU as soon as delirium assessment was pos-
sible after awakening from sedation. To exclude a
potential source of bias, assessors of the CAM-ICU were
not made aware of the fact that they were collecting data
for this study [31].
In order to check the quality of the delirium assess-
ments, compliance with the CAM-ICU was per
participating centre calculated monthly as the percentage
of assessments performed per day in relation to the total
number of assessments that should have been performed.
Also, inter-rater reliability (IRR) measurements of the
CAM-ICU were performed by duplicate measurements of
the CAM-ICU for all admitted ICU patients, on one given
day per month per centre, by comparing CAM-ICU scores
assessed by the ICU nurse with the scores assessed by a
CAM-ICU expert. CAM-ICU experts and ICU nurses
were blinded to each others delirium assessments. If per
centre, the CAM-ICU screening compliance was above
80 % and the Cohen’s kappa was above 0.80, their data
were considered reliable. Centres that did not meet these
criteria were per centre excluded from the analysis, after
which re-analysis was performed. If exclusion of a centre
did not significantly affect the performance of the E-PRE-
DELIRIC model, the centre was included in the final
analysis, as the data were considered to be of sufficient
quality [23, 24].
Sensitivity and specificity of the delirium assessments
were calculated using the CAM-ICU outcomes obtained by
CAM-ICU experts compared with those of the ICU nurses.
Outcome definition
The primary outcome of this study was the development
of ICU delirium, defined as a positive assessment for
delirium during a patient’s complete ICU stay.
Statistical analysis
Statistical analyses, including information regarding
missing values, are described in Supplemental file 1 on-
line data supplement. The model was developed using
multiple logistic regression analysis on data of the first
two-thirds of the patients of all participating hospitals.
Selection of the final predictors of the E-PRE-DELIRIC
model took place through manual backward selection of
the candidate predictors using a P value of [0.10 for
exclusion. The model was validated on data of the last
one-third of the patients. Discriminative power was
assessed using the area under the receiver operating
characteristic curve (AUROC) [31]. Calibration was
assessed graphically by plotting the observed outcome
frequencies against the mean predicted outcome prob-
abilities or risks, within subgroups of patients that were
ranked by increasing estimated probability [32]. To
evaluate the predictive value of the E-PRE-DELIRIC
model related to the moment at which delirium first oc-
curred, the database was divided into four groups based
on the quartiles of the time to development of delirium at:
days 0–1; day 2; days 3–6;[day 6.
Data were analyzed using IBM SPSS Statistics
20.01 and R statistics R 3.0.1 [33]. In this study, we used
the Transparent Reporting of a multivariable prediction
model for individual prognosis or diagnosis (TRIPOD), a
strict methodology for data reporting, to check our ad-
herence to suggested optimal levels of transparency and
completeness of reporting of a prediction model [34].
Sample size calculation
The E-PRE-DELIRIC model was compiled from 18
candidate predictors. For each candidate predictor, at least
ten patients with delirium were needed for the validation
and calibration of the model [35]. With an anticipated
delirium incidence of 15–30 %, an expected attrition of
25 %, we aimed to enrol at least (18 9 10/0.15)/
0.75 = 1600 patients.
Results
In total, 5352 patients were screened, of whom 2438 pa-
tients did not fulfil the inclusion criteria (Fig. 1). The
cohort consisted of 2914 patients of whom 1962 patients
were included in the development dataset. The ICU
delirium incidence was 24.5 %. The remaining 952 pa-
tients were included in the validation dataset with an ICU
delirium incidence of 21.8 %. The demographic charac-
teristics of both groups were comparable (Table 1).
CAM-ICU compliance and inter-rater reliability
As exclusion of the centres with a CAM-ICU screening
compliance \80 % and/or a Cohen’s kappa \0.80 did
not significantly affect the performance of the E-PRE-
DELIRIC model, all centres were subsequently included
in the final analysis. The overall CAM-ICU compliance
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was 83 % (Q1–Q3: 78–93). In total, 648 inter-rater
CAM-ICU measurements were performed. The mean
IRR measurements were 0.83 [95 % confidence interval
(CI) 0.78–0.88] Cohen’s kappa (Table E3 online data
supplement). The CAM-ICU had a sensitivity of 0.82
(95 % CI 0.76–0.87) and a specificity of 0.98 (95 % CI
0.96–0.99).
Discrimination and calibration of the E-PRE-
DELIRIC model
The developed E-PRE-DELIRIC model consists of nine
predictors: age, history of cognitive impairment, history
of alcohol abuse, BUN at time of ICU admission, ad-
mission category, urgent admission, MAP at the time of
ICU admission, use of corticosteroids, and respiratory
failure (Table 2). The discriminative power (AUROC)
was 0.76 (95 % CI 0.73–0.78) in the development dataset.
This database was divided in groups based on the
quartiles of the predicted probabilities for delirium de-
velopment: very low (0–10 %), low (10–20 %), moderate
(20–35 %), and high risk for delirium ([35 %). For each
of these groups, the sensitivity, specificity and likelihood
ratios were calculated (Fig. 2). At a cut-off of 24.5 %,
which was the ICU delirium incidence in the development
dataset, the sensitivity and specificity were 71 and 69 %,
respectively. The AUROC was 0.75 (95 % CI 0.71–0.79)
in the validation dataset (see Figure E1 online data sup-
plement for the calibration plot of the validation dataset).
Fitting the model Log(Odds) = b0 ? b1 9 LP on the
observed data showed that recalibration was not neces-
sary. The slope of the model was 0.961 with an intercept
of -0.094.
Prediction of early and late development of delirium
In patients who developed delirium at days 0–1 the
AUROC was 0.70 (95 % CI 0.67–0.74) with a sensitivity
Table 1 Patient characteristics
Variable Development dataset
(n = 1962)
Validation dataset
(n = 952)
Whole study
population (n = 2914)
Age in years, mean (Q1–Q3, min/max) 61.7 (53–74, 18/95) 60.6 (51–73, 18/94) 61.3 (52–73, 18/95)
Male, n (%) 1166 (59.4) 550 (57.8) 1716 (58.9)
Admission category, n (%)
Surgery 1019 (51.9) 476 (50.0) 1495 (51.3)
Medical 683 (34.8) 338 (35.5) 1021 (35.0)
Trauma 90 (4.6) 44 (4.6) 134 (4.6)
Neurology/neurosurgery 170 (8.7) 94 (9.9) 264 (9.1)
Urgent admission, n (%) 1163 (59.3) 570 (59.9) 1733 (59.5)
LOS-ICU in days, median (Q1–Q3, min/max) 2.0 (1–6, 1/133) 2.0 (1–5, 1/125) 2.0 (1–5, 1/133)
Delirium, n (%) 481 (24.5) 208 (21.8) 689 (23.6)
Table 2 Variables of the E-PRE-DELIRIC model and regression coefficients and formula for the E-PRE-DELIRIC model
Variable Regression coefficient Odds ratio (95 % CI)
Age 0.025 1.025 (1.017–1.033)
History of cognitive impairment 0.878 2.406 (1.700–3.404)
History of alcohol abuse 0.505 1.657 (1.170–2.347)
Admission category
Surgery RC RC
Medical 0.370 1.448 (1.058–1.982)
Trauma 1.219 3.384 (1.997–5.735)
Neurology/neurosurgery 0.504 1.655 (1.064–2.575)
Urgent admission 0.612 1.843 (1.326–2.563)
MAP at the time of ICU admission -0.006 0.994 (0.988–1.001)
Use of corticosteroids 0.283 1.327 (0.996–1.768)
Respiratory failure 0.982 2.670 (2.099–3.396)
BUN at time of ICU admission 0.018 1.018 (1.006–1.031)
Data development set. Formula for the E-PRE-DELIRIC model:
Risk of delirium = 1/[1 ? exp - (-3.907 ? 0.025 9 age ? 0.878
for history of cognitive impairment ? 0.505 for history of alcohol
abuse ? 0 for surgery or 0.370 for medical or 1.219 for trauma
or 0.504 for neurology/neurosurgery ? 0.612 for urgent admission
- 0.006 9 MAP at the time of ICU admission ? 0.283 for use of
corticosteroids ? 0.982 for respiratory failure ? 0.018 x BUN in
mmol/l at time of ICU admission)]
RC reverence category
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and specificity of 62 and 67 %, respectively. This in-
creased to 0.76 (95 % CI 0.72–0.80) (development of
delirium at day 2), 68 and 67 %; 0.77 (95 % CI
0.74–0.80) (development of delirium at days 3–6), 72 and
68 %; and 0.81 (95 % CI 0.78–0.84) (development of
delirium after day 6), 78 and 68 %, respectively. The
predictive value of the model improved significantly over
time (Fig. 3).
Discussion
In this prospective, international multicentre study, we
developed and validated a model allowing early predic-
tion of patients likely to develop delirium during ICU
admission. Using nine predictors that are readily available
at ICU admission, it is now possible to stratify ICU pa-
tients for delirium risk for the complete ICU length of
stay with a high discriminative power. In contrast to the
earlier prediction model [23, 24], which reliably predicts
delirium using data available only after 24 h in the ICU,
our E-PRE-DELIRIC model has a moderate-to-good
performance using data available immediately at ICU
admission. Of interest, the predictive accuracy of the
model is higher for delirium that develops later compared
to delirium that develops early following ICU admission.
In view of the high prevalence of delirium in ICU
patients [2, 3] and its serious consequences [3–6], pre-
diction of ICU delirium is clearly of clinical relevance as
Cutoff  Sensitivity Specificity Positive likelihood ratio Negative likelihood ratio 
10% 94 32 1.4 0.2 
20% 4.09.18508
35% 50 83 2.9 0.6 
67.5% 9.09.8996
Fig. 2 Area under the receiver operating characteristic curve (AUROC) of development dataset (AUROC = 0.76)
Fig. 3 Area under the receiver operating characteristic curve
(AUROC) during ICU stay. Error bars 95 % CIs
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early risk identification may serve different purposes.
Both caregivers and patients families can be informed
early about the risk of developing delirium in the ICU,
and this may, for example, assist them in taking decisions
related to the use of preventive measures. In addition, the
model enables stratification for the risk to develop delir-
ium, which may be helpful in future trials that aim to
investigate preventive interventions. Our group previ-
ously reported the effects of prevention with low-dose
haloperidol in critically ill patients using a prediction
model and demonstrated that patients with the highest risk
appear to benefit most from prevention [18]. With the
E-PRE-DELIRIC model, stratification is possible imme-
diately after ICU admission. Various other preventive
measures that target modifiable delirium risk factors have
been found beneficial in non-critically ill patients [8, 10,
11] and need confirmation in ICU patients. In these
confirmation trials, stratification of the a priori risk to
develop delirium should be determined to demonstrate
that treatment groups are adequately randomized. As a
consequence, possible interventions that may be expen-
sive and/or labour intensive can then be provided only to
those patients with highest risk. In this way, improved
quality and efficiency of care may be achieved in a cost-
effective manner [36].
The predictors that build the E-PRE-DELIRIC-model
are largely consistent with previously reported risk factors
for delirium, including age, pre-existing dementia, history
of alcoholism, and a high severity of illness at admission
[8, 37, 38]. Other factors that confirm previously reported
predictors include admission category, urgent admission,
BUN [23, 24], and respiratory failure [37–39]. While use
of corticosteroids was not reported as a relevant factor in
another study [2], in our study the use of corticosteroids
was a significant predictor for delirium. We only collected
data about corticosteroids use at ICU admission, in con-
trast, the authors of [2] collected daily data about
corticosteroids use during the whole study period. Of
importance, as relevant differences between countries
may exist, the current study was a multinational study
using data of ICUs from different countries for the de-
velopment of a delirium prediction model, which
increases its generalisability. Interestingly, while the
delirium incidence remains stable over time in the four
groups in this study, the predictive value of the model
increases over time. However, examining differences
between early and late delirium did not fall within the
scope of this study, and therefore should be studied in
future research.
Several limitations of this study need to be addressed.
First, despite the fact that availability of candidate pre-
dictors at ICU admission and the effort it would take to
collect the data in daily clinical practice were leading in
determining candidate predictors, three of the predictors
from the E-PRE-DELIRIC model (BUN, history of al-
cohol abuse, and cognitive impairment) had a fairly high
rate of missing values. Probably due to unawareness of
the importance of these predictors for delirium prediction,
currently these predictors are not collected in a stan-
dardised manner in daily practice. When health
professionals need the information about these predictors
to be able to use the E-PRE-DELIRIC model, they will
(most often) be able to collect the information as they are
readily available. We used imputation techniques to
handle missing data. Multiple imputation helps to reduce
bias and increases precision by including variation of data
[31]. Second, the performance of the CAM-ICU in daily
practice is not optimal [40–42]. However, in contrast to
the evaluation study of Van Eijk et. al [40], in the current
study ICU patients were screened for delirium at least two
times daily and during the whole ICU length of stay. This
increases the chance of correct delirium scores, because
of the fluctuating course of delirium. The scores were
determined in the same way in all participating ICUs,
positively influencing possible measurement bias. In ad-
dition, data on the use of haloperidol and other anti-
psychotics for delirium were used [23]. This usage was
consistent among the different centres. Therefore, we may
assume that sensitivity of the bedside nurse to recognize
delirium anywhere during ICU admission is high. The
quality of data of the CAM-ICU screening was further
improved by determination of compliance and inter-rater
reliability in each ICU. Third, although the full model
approach to include all 18 candidate predictors in the
predictive model is likely to avoid overfitting and selec-
tion data [43], we chose to perform manual backward
selection of predictors to improve the clinical feasibility.
Fourth, based on the predetermined exclusion criteria, a
large number of patients had to be excluded. One of these
exclusion criteria was an ICU stay shorter than one day.
Since the E-PRE-DELIRIC model will be used prospec-
tively following ICU admission, one may not be able to
anticipate a patient’s ICU length of stay (LOS). There-
fore, for each patient admitted to the ICU, the E-PRE-
DELIRIC score will be calculated. Predictions for pa-
tients with an ICU LOS shorter than one day might be
different than those for patients with an ICU LOS longer
than one day. Therefore, in future research, it is recom-
mended to include these patients to determine the
influence on the performance of the E-PRE-DELIRIC
model. Finally, it should be taken into account that se-
lection of candidate predictors in the E-PRE-DELIRIC
model might be biased. However, the candidate predictors
were based on multiple scientific sources, including the
previously published PRE-DELIRIC model [23, 24], a
systematic review about delirium risk factors [29], and
expert opinion. Although external validation of the
E-PRE-DELIRIC model in new centres was not per-
formed, this prediction model was internationally
developed and prospectively validated in 13 ICUs from
seven different countries. The E-PRE-DELIRIC model is
a result of a relevant sample from these ICUs, and
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therefore widely applicable and probably generalisable to
other countries. ICUs should consider, however, that the
prediction of delirium derived from the E-PRE-DELIRIC
model is an approximation; there can always be some
over- or underestimation in the predicted delirium risk.
Therefore, for future research, it is recommended to test
the external validity of the E-PRE-DELIRIC model in
other centres to further improve its generalisability.
In conclusion, in this multinational study, we devel-
oped and validated an early ICU delirium prediction
model that revealed sufficient validity. It enables the
clinician to identify those patients likely to develop
delirium following ICU admission using only nine pre-
dictors. The model allows early delirium preventive
interventions in ICU patients with a high risk of delirium.
An automatic version of the E-PRE-DELIRIC model
(Excel and web-based) will soon be available at https://
www.radboudumc.nl/Research/Organisationofresearch/
Departments/intensive%20care/Pages/vandenBoogaard.
aspx.
(In multiple languages available). Furthermore the
E-PRE-DELIRIC model will soon be integrated in the
DeliriumICU app which makes it possible to use it bed-
side (http://itunes.apple.com/us/app/deliriumicu/id511306
390 and https://play.google.com/store/apps/details?id=dots
digits.deliriumicu).
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